Plant-dominant low-protein diet versus standard care in adults with chronic kidney disease stages 3–5: A randomized controlled trial protocol
Nutrition Research · 2026-07 · 151 · 1-15
DOI: 10.1016/j.nutres.2026.04.004 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrition Research, 2026-07. Verfasst von Joelle Abi Kharma und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Food Science, Lebanese American University, Byblos, Lebanon; Department of Health Promotion, NUTRIM School of Nutrition a…. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Diet, Protein-Restricted. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lebanese American University, American University, Zayed University.
Abstract (Originalsprache)
BACKGROUND: The plant-dominant low-protein diet (PLADO), providing 0.6-0.8 g/kg/d of protein with ≥50% derived from plant sources, may improve acid-base balance and metabolic outcomes in chronic kidney disease (CKD). However, concerns remain regarding safety and feasibility, and experimental evidence is limited. OBJECTIVE: This protocol describes a randomized controlled trial (RCT), designed to evaluate the efficacy, nutritional and biochemical safety, implementation feasibility, and cost-effectiveness of PLADO compared with the standard renal diet in adults with CKD stages 3-5. METHODS: This unblinded, parallel-group RCT will enroll 48 adults with CKD stages 3-5 in a medical center in Lebanon and randomize participants 1:1 to PLADO or standard-of-care renal diet for 6 months, followed by a 3-month free-living phase. Both groups will receive monthly individualized dietary counselling. OUTCOMES: The primary outcome is change in metabolic acidosis between groups, assessed by plasma total CO₂ from baseline to 6 months. Improvements in acid-base status are hypothesized to result from reduced dietary acid load, increased fiber intake, and favourable gut microbiota-related metabolic changes. Secondary outcomes include biochemical markers (uremia and anemia markers, electrolytes), nutritional status (GLIM criteria), gastrointestinal symptoms, quality-of-life (EQ-5D-5 L), gut microbiota composition, and cost-effectiveness. A mixed methods process evaluation will assess intervention fidelity, adherence, and reach. EXPECTED CONTRIBUTION: This trial will provide experimental evidence on the efficacy, safety, and feasibility of PLADO in the conservative management of CKD stages 3-5, informing dietary practice in resource-limited settings, where healthcare delivery is challenged by limited insurance coverage and economic instability. TRIAL REGISTRATION: NCT06932042.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition and Food Science, Lebanese American University, Byblos, Lebanon; Department of Health Promotion, NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine &…
- Department of Health Promotion, NUTRIM School of Nutrition and Translational Research in Metabolism, Faculty of Health, Medicine & Life Sciences, Maastricht University, Maastricht, N/A, The Netherlands.
- Department of Nutrition and Food Science, Lebanese American University, Byblos, Lebanon; Institut National de Santé Publique, d'Epidémiologie Clinique, et de Toxicologie (INSPECT-LB), Beirut, Lebanon. Electronic address…
- Department of Health Sciences, College of Natural and Health Sciences (CNHS), Zayed University, Dubai, United Arab Emirates.
- Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University, Byblos, Lebanon; Department of Internal Medicine, Division of Nephrology, LAU Medical Center-Rizk Hospital, Achrafieh, Beirut, Lebanon.
- Harbor-UCLA Medical Center, the Lundquist Institute, Torrance, CA, USA; UCLA Geffen School of Medicine, Los Angeles, California, USA; UCLA Fielding School of Public Health, Los Angeles, California, USA.
Förderung
- Lebanese American University
- American University
- Zayed University
Zitieren
APA
Kharma, J. A., Sultan, R., Rizk, R., Haroun, D., Kilani, H., Kalantar-Zadeh, K., Gubbels, J., & Bessems, K. (2026). Plant-dominant low-protein diet versus standard care in adults with chronic kidney disease stages 3–5: A randomized controlled trial protocol. Nutrition Research, 151, 1-15. https://doi.org/10.1016/j.nutres.2026.04.004
Vancouver
Kharma JA, Sultan R, Rizk R, Haroun D, Kilani H, Kalantar-Zadeh K, et al. Plant-dominant low-protein diet versus standard care in adults with chronic kidney disease stages 3–5: A randomized controlled trial protocol. Nutrition Research. 2026;151:1-15. doi:10.1016/j.nutres.2026.04.004
BibTeX
@article{Kharma2026,
author = {Kharma, Joelle Abi and Sultan, Rana and Rizk, Rana and Haroun, Dalya and Kilani, Hala and Kalantar-Zadeh, Kamyar and Gubbels, Jessica and Bessems, Kathelijne},
title = {Plant-dominant low-protein diet versus standard care in adults with chronic kidney disease stages 3–5: A randomized controlled trial protocol},
journal = {Nutrition Research},
year = {2026},
volume = {151},
pages = {1--15},
doi = {10.1016/j.nutres.2026.04.004}
}
EUVIMED